Serological response following BNT162b2 anti-SARS-CoV-2 mRNA vaccination in haematopoietic stem cell transplantation patients.

Immacolata AttolicoFrancesco TarantiniPaola CarluccioClaudia Pia SchifoneMario DeliaVito Pier GagliardiTommasina PerroneFrancesco GaudioChiara LongoAnnamaria GiordanoNicola SgherzaPaola CurciRita RizziAlessandra RiccoAntonella Russo RossiFrancesco AlbanoAngela Maria Vittoria LaroccaLuigi VimercatiSilvio TafuriPellegrino Musto

Published in: British journal of haematology (2021)

Keyphrases

stem cell transplantation
sars cov
high dose
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
low dose
patient reported outcomes
respiratory syndrome coronavirus